Q2 2015 13F Holders as of 6/30/2015
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
73
-
Total shares
-
11.6M
-
Shares change
-
+2.66M
-
Total reported value, excl. options
-
$204M
-
Value change
-
+$51.4M
-
Put/Call ratio
-
0.47
-
Number of buys
-
51
-
Number of sells
-
-35
-
Price
-
$17.62
Significant Holders of SORRENTO THERAPEUTICS INC - Common Stock (SRNE) as of Q2 2015
78 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - Common Stock as of Q2 2015.
SORRENTO THERAPEUTICS INC - Common Stock (SRNE) has 73 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.6M shares
.
Largest 10 shareholders include venBio Select Advisor LLC (2.19M shares), Cormorant Asset Management, LLC (1.95M shares), VANGUARD GROUP INC (750K shares), BlackRock Fund Advisors (742K shares), Wildcat Capital Management, LLC (736K shares), BlackRock Institutional Trust Company, N.A. (648K shares), FRANKLIN RESOURCES INC (339K shares), Baird Financial Group, Inc. (306K shares), STATE STREET CORP (293K shares), and DEUTSCHE BANK AG\ (268K shares).
This table shows the top 73 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.